
Allison Ross
Articles
-
Jan 22, 2025 |
ancavasculitisnews.com | Margarida Maia |Marisa Wexler |Allison Ross
Physicians typically do not overestimate the overall health of people with ANCA-associated vasculitis (AAV), a study of global assessments made by patients and their doctors in Australia reports. In cases where ratings between these two groups markedly differed, doctors tended to assign a lower score than did the people evaluating their own health.
-
Jan 13, 2025 |
ancavasculitisnews.com | Margarida Maia |Allison Ross |Katherine Poinsatte |Andrea Lobo
Adicet Bio has pushed to the second half of 2025 the expected timing for enrolling patients with ANCA-associated vasculitis (AAV) in an ongoing Phase 1 clinical trial testing ADI-001, an experimental CAR T-cell therapy for a number of autoimmune diseases.
-
Nov 27, 2024 |
ancavasculitisnews.com | Andrea Lobo |Lindsey Shapiro |Allison Ross |Margarida Maia
Most children with granulomatosis with polyangiitis (GPA) have respiratory manifestations including cough and shortness of breath at diagnosis, and these frequently persist or relapse, according to a study in the U.S. involving 13 pediatric patients. Lung abnormalities were detected in nearly all children with available imaging data at diagnosis regardless of respiratory symptoms.
-
Oct 9, 2024 |
ancavasculitisnews.com | Esteban Cerezo |Andrea Lobo |Allison Ross |Mary Chapman
The Vasculitis Foundation has announced the launch of a new support group for young adults with vasculitis, a group of autoimmune conditions that includes ANCA-associated vasculitis (AAV). The group will promote connections among young adults, from 18 to 30 years of age, living with vasculitis, which is marked by blood vessel inflammation.
-
Aug 14, 2024 |
ancavasculitisnews.com | Margarida Maia |Patricia Inacio |Lindsey Shapiro |Allison Ross
Conduit Pharmaceuticals is planning to launch Phase 2a clinical trials to test its lead oral candidate AZD1656 in people with immune system disorders — specifically ANCA-associated vasculitis (AAV) as one indication.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →